Review
Drug evaluation: ranirestat--an aldose reductase inhibitor for the potential treatment of diabetic complications
Affiliations
- PMID: 17086937
Item in Clipboard
Review
Drug evaluation: ranirestat--an aldose reductase inhibitor for the potential treatment of diabetic complications
Curr Opin Investig Drugs.
2006 Oct.
Abstract
Ranirestat is an orally available aldose reductase inhibitor under development by Dainippon Sumitomo Pharma Co Ltd (formerly Dainippon Pharmaceutical Co Ltd), Kyorin Pharmaceutical Co Ltd and Eisai Co Ltd for the potential treatment of diabetic complications, such as neuropathy, cataracts, retinopathy and nephropathy. Phase III trials were ongoing in February 2006.
Similar articles
-
Evaluation of ranirestat for the treatment of diabetic neuropathy.Expert Opin Drug Metab Toxicol. 2014 Jul;10(7):1051-9. doi: 10.1517/17425255.2014.916277. Epub 2014 Apr 30. Expert Opin Drug Metab Toxicol. 2014. PMID: 24785785 Review.
-
Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications.Expert Opin Investig Drugs. 2008 Apr;17(4):575-81. doi: 10.1517/13543784.17.4.575. Expert Opin Investig Drugs. 2008. PMID: 18363521 Review.
-
Inventing and understanding catalytic, enantioselective reactions.Curr Opin Drug Discov Devel. 2009 Nov;12(6):862-75. Curr Opin Drug Discov Devel. 2009. PMID: 19894195 Review.
-
Fidarestat. Sanwa Kagaku/NC Curex/Sankyo.Curr Opin Investig Drugs. 2003 Oct;4(10):1233-9. Curr Opin Investig Drugs. 2003. PMID: 14649216 Review.
-
Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review.J Diabetes Complications. 2010 Sep-Oct;24(5):354-60. doi: 10.1016/j.jdiacomp.2009.07.005. Epub 2009 Sep 11. J Diabetes Complications. 2010. PMID: 19748287 Review.
Cited by
-
Recent Progress on the Stereoselective Synthesis of Cyclic Quaternary alpha-Amino Acids.Tetrahedron Asymmetry. 2009 Jan 30;20(1):1-63. doi: 10.1016/j.tetasy.2009.01.002. Tetrahedron Asymmetry. 2009. PMID: 20300486 Free PMC article.
-
Phlorotannins: Towards New Pharmacological Interventions for Diabetes Mellitus Type 2.Molecules. 2016 Dec 30;22(1):56. doi: 10.3390/molecules22010056. Molecules. 2016. PMID: 28042834 Free PMC article. Review.
-
Aldose reductase, oxidative stress, and diabetic mellitus.Front Pharmacol. 2012 May 9;3:87. doi: 10.3389/fphar.2012.00087. eCollection 2012. Front Pharmacol. 2012. PMID: 22582044 Free PMC article.
-
Binding Studies of Caffeic and p-Coumaric Acid with α-Amylase: Multispectroscopic and Computational Approaches Deciphering the Effect on Advanced Glycation End Products (AGEs).Molecules. 2022 Jun 21;27(13):3992. doi: 10.3390/molecules27133992. Molecules. 2022. PMID: 35807235 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical